JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WINGARD, L. B.
Right arrow Articles by LEVY, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WINGARD, L. B., JR.
Right arrow Articles by LEVY, G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 184, Issue 1, 253-260, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


KINETICS OF ANTICOAGULANT EFFECT OF DICUMAROL IN RATS

LEMUEL B. WINGARD JR. 1 and GERHARD LEVY 1

1 Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo, Buffalo, New York

The purposes of this study were 1) to determine the relationship between plasma-dicumarol concentration and anticoagulant effect in rats and 2) to compare the kinetics of the anticoagulant effect of dicumarol in the rat and man. Special methodology was developed for repeated determination of dicumarol concentration and prothrombin complex activity in individual animals. The inhibition of prothrombin complex activity synthesis rate at any time could be related quantitatively to the dicumarol concentration in the plasma. This permits a quantitative description of the time course of the anticoagulant effect in relation to the elimination kinetics of dicumarol. There are quantitative differences between rats and man in the pharmacokinetic constants for dicumarol elimination, for synthesis and degradation of vitamin K-dependent clotting factors as reflected by prothrombin complex activity and for the relationship between drug concentration and effect, but the pharmacokinetic relationships are basically the same. Consequently, the rat can be a useful animal model for studying various drug interactions and other factors which modify the activity of coumarin anticoagulants.

Submitted on May 4, 1972
Accepted on August 9, 1972







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.